Skip to content

Video Documentation of Localized Complications

Video Documentation of Localized Complications in IV Cannulation Using Near-Infrared Technology

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01453322
Enrollment
10
Registered
2011-10-17
Start date
2011-09-30
Completion date
2011-09-30
Last updated
2011-10-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vascular Access

Keywords

Veins, Vascular Access, IV complications, VeinViewer Vision

Brief summary

The objective of this study is to confirm and document that with the use of a FDA Class I exempt near infrared device, VeinViewer® Vision that is hands-free and can be used for healthy adult volunteers with varying skin types to assist in the improved visualization, it is possible to film, analyze and document PIV localized complications and venous flow and refill.

Interventions

None listed

Sponsors

Christie Medical Holdings, Inc.
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Must be 18 years of age or older * Must be considered in good health by investigator * Must be able to read and understand English

Exclusion criteria

* Less than 18 years of age * Known allergy to Heparin * History of HIT (Heparin-induced thrombocytopenia) * Unable to read and understand English

Design outcomes

Primary

MeasureTime frameDescription
Valve and Refill ConfirmationImmediately after flush-Day 1Using VeinViewer, the clinician will be able to view valves and refill. It will be confirmed using Ultrasound.

Secondary

MeasureTime frameDescription
Video Documentation of localized vascular access complicationsImmediately after attempt-Day 1Using VeinViewer, the user will be able to detect hematomas and infiltrations.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026